Fabian Tenenbaum
2018
In 2018, Fabian Tenenbaum earned a total compensation of $2.3M as Chief Executive Officer at Bellerophon Therapeutics, a 286% increase compared to previous year.
Compensation breakdown
| Bonus | $240,000 |
|---|---|
| Option Awards | $1,659,781 |
| Salary | $400,624 |
| Other | $16,500 |
| Total | $2,316,905 |
Tenenbaum received $1.7M in option awards, accounting for 72% of the total pay in 2018.
Tenenbaum also received $240K in bonus, $400.6K in salary and $16.5K in other compensation.
Rankings
In 2018, Fabian Tenenbaum's compensation ranked 4,999th out of 14,244 executives tracked by ExecPay. In other words, Tenenbaum earned more than 64.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,999 out of 14,244 | 65th |
Division Manufacturing | 1,880 out of 5,765 | 67th |
Major group Chemicals And Allied Products | 690 out of 2,128 | 68th |
Industry group Drugs | 577 out of 1,817 | 68th |
Industry Pharmaceutical Preparations | 444 out of 1,391 | 68th |
Source: SEC filing on March 28, 2019.
Tenenbaum's colleagues
We found two more compensation records of executives who worked with Fabian Tenenbaum at Bellerophon Therapeutics in 2018.